IFNG and neoplasm: Oncolytic viruses targeting tumor cells cause less immune-tolerant tumor microenvironment, thereby causing subsequent cytokine expression, which acts synergistically with checkpoint inhibitors by increasing tumor CD8+ and interferon gamma (IFN-gamma) signaling and up-regulating PD-L1 in the tumor microenvironment.